Skip to content

Thursday, May 19, 2022

Latest:

KYORIN and Eisai Enter Into License Agreement Concerning the Development and Marketing of Vibegron, a Treatment for Overactive Bladder, in Four ASEAN Countries
The Valens Company to Hold Conference Call to Discuss Financial Results for the First Quarter of 2021
AlumiFuel Reduces the Authorized Number of Shares
Seqirus Ready to Reinforce Canada’s Influenza Pandemic Preparedness Plans
FACT, Inc. Announces Patricia Trompeter as CEO

Biotech Research Report

Know First, Act First

Covid-19
General
Cannabis
Fiscal & Financing
Pharmaceutical
Trending

Cannabis

BIOTCHNO Cannabis

SiliCycle signs a Letter of Intent with the Société Québécoise du Cannabis (SQDC)

February 15, 2021April 14, 2021 Bachittar

SiliCycle signs a Letter of Intent with the Société Québécoise du Cannabis (SQDC) QUEBEC CITY , Dec. 15, 2020 /CNW

BIOTCHNO Cannabis

Nutra Pharma Provides Updates on Progress of their Nerve Agent Countermeasures

November 18, 2020April 19, 2021 vanessa

Nutra Pharma Provides Updates on Progress of their Nerve Agent Countermeasures Nutra Pharma is providing updates on their work in

Cannabis

BIOTCHNO Cannabis

SiliCycle signs a Letter of Intent with the Société Québécoise du Cannabis (SQDC)

February 15, 2021April 14, 2021 Bachittar

SiliCycle signs a Letter of Intent with the Société Québécoise du Cannabis (SQDC) QUEBEC CITY , Dec. 15, 2020 /CNW

BIOTCHNO Cannabis

Nutra Pharma Provides Updates on Progress of their Nerve Agent Countermeasures

November 18, 2020April 19, 2021 vanessa

Disclaimer
Privacy Policy

TD Media LLC dba Life Water Media
1415 South Voss Road Suite 110-431 Houston, TX 77057